Skip to main content
Recall Canary
Aripiprazole 30 mg Tablets
← Back to all recalls
DRUG RECALLMODERATE

Aripiprazole 30 mg Tablets

Ajanta Pharma is recalling Aripiprazole 30 mg tablets due to a mix-up with Voriconazole 50 mg tablets.

What to do

Check your medication bottle immediately to ensure it contains the correct tablets. If you have received Voriconazole instead of Aripiprazole, stop using the product and contact your pharmacist or healthcare provider.

Recalled
Listed
Updated
Recall No.
D-0594-2026
Agency
FDA
Firm
Ajanta Pharma USA Inc
Recall ID
99046
Status
ONGOING

Recall at a glance

Quantity recalled
6,143 bottles

Why it was recalled

Ajanta Pharma is recalling one lot of Aripiprazole 30 mg tablets due to a product mix-up where bottles were found to contain Voriconazole 50 mg tablets instead. Consuming the incorrect medication poses a risk of adverse health effects.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Aripiprazole Tablets USP, Rx only

Lot code
PA00805, 2029
Strength
30 mg
NDC / UPC
NDC 27241-056-03

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Other Labeling Error recalls

Other recent recalls from Ajanta Pharma USA Inc

All recalls from Ajanta Pharma USA Inc

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-06-17 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification